Cardiomyopathy in duchenne, becker, and sarcoglycanopathies: a role for coronary dysfunction?

T Gnecchi-Ruscone1, J Taylor, E Mercuri

  • 1MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK.

Muscle & Nerve
|October 8, 1999
PubMed

Insights

Dilated cardiomyopathy in Duchenne and sarcoglycanopathy patients shows impaired coronary vasodilator reserve due to increased baseline blood flow. This finding offers insights into muscular dystrophy cardiac complications.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Background:

  • Dilated cardiomyopathy is a known complication of Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and sarcoglycanopathies.
  • The underlying mechanisms of cardiomyopathy in these muscular dystrophies remain poorly understood.
  • Coronary smooth muscle dysfunction is implicated in myotonic dystrophy cardiomyopathy.

Purpose of the Study:

  • To investigate myocardial blood flow and coronary vasodilator reserve in patients with Duchenne muscular dystrophy, Becker muscular dystrophy, and sarcoglycanopathies.
  • To elucidate the role of coronary circulation in the pathogenesis of cardiomyopathy in these genetic disorders.

Main Methods:

  • Positron emission tomography (PET) was utilized to assess myocardial blood flow and coronary vasodilator reserve.
  • Measurements were taken at baseline and during hyperemia in patients with Duchenne muscular dystrophy (n=7), Becker muscular dystrophy (n=8), and sarcoglycanopathies (n=5).

Main Results:

  • All Becker muscular dystrophy patients exhibited normal findings.
  • Duchenne muscular dystrophy and sarcoglycanopathy patients displayed increased baseline myocardial blood flow and blunted coronary vasodilator reserve.
  • The diminished coronary vasodilator reserve was attributed to elevated baseline myocardial blood flow.
  • After adjusting for cardiac workload, coronary vasodilator reserve normalized in Duchenne muscular dystrophy but remained abnormal in sarcoglycanopathies.

Conclusions:

  • Coronary vasodilator reserve is impaired in Duchenne muscular dystrophy and sarcoglycanopathies, independent of hyperemic flow.
  • In Duchenne muscular dystrophy, the impairment appears related to cardiac workload, while vascular smooth muscle dysfunction may contribute in sarcoglycanopathies.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...